Preferred Drug List Changes
The following changes have been made to the Nebraska PDL. Changes are effective July 22, 2022.
| Nebraska PDL Therapeutic Drug Class | Change effective July 22, 2022 |
|---|---|
| ACNE AGENTS, TOPICAL | CLINDAMYCIN PHOSPHATE/BENZOYL PEROXIDE -> NON PREFERRED |
| ANGIOTENSIN MODULATORS | FOSINOPRIL SODIUM -> NON PREFERRED FOSINOPRIL SODIUM/HYDROCHLOROTHIAZIDE -> NON PREFERRED |
| ANTIBIOTICS, VAGINAL | VANDAZOLE -> NON PREFERRED METRONIDAZOLE VAGINAL -> PREFERRED |
| ANTIMIGRAINE AGENTS, OTHER | NURTEC -> PREFERRED |
| BONE RESORPTION SUPRESSION AND RELATED DRUGS | TERIPARATIDE -> NON PREFERRED FORTEO -> PREFERRED |
| CONTRACEPTIVES, ORAL | DOLISHALE -> PREFERRED NEXTSTELLIS -> PREFERRED |
| GROWTH HORMONES | NUTROPIN AQ -> PREFERRED |
| HIV/AIDS COMBINATION NRTI | TRUVADA -> NON PREFERRED EMTRICITABINE/TENOFOVIR DISOPROXIL -> PREFERRED |
| HIV/AIDS COMBINATION PRODUCTS MISC | ATRIPLA -> NON PREFERRED DOVATO -> PREFERRED EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE -> PREFERRED |
| HIV/AIDS PROTEASE INHIBITORS | LEXIVA -> NON PREFERRED |
| HYPOGLYCEMICS, DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITOR | GLYXAMBI -> NON PREFERRED |
| HYPOGLYCEMICS, GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1 RA) | BYETTA -> NON PREFERRED OZEMPIC -> PREFERRED |
| HYPOGLYCEMICS, INSULIN AND RELATED DRUGS | NOVOLOG MIX 70/30 -> NON PREFERRED NOVOLIN N FLEXPEN -> PREFERRED NOVOLIN R FLEXPEN -> PREFERRED |
| IMMUNOSUPPRESSIVES, ORAL | ZORTRESS -> NON PREFERRED EVEROLIMUS -> PREFERRED |
| MACROLIDES AND KETOLIDES, ORAL | ERYTHROMYCIN ETHYLSUCCINATE -> NON PREFERRED E.E.S. GRANULES -> PREFERRED |
| MULTIPLE SCLEROSIS DRUGS | TECFIDERA -> NON PREFERRED DIMETHYL FUMARATE -> PREFERRED |
| PAH (PULMNOARY ARTERIAL HYPERTENSION AGENTS), ORAL AND INHALED | SILDENAFIL CITRATE -> NON PREFERRED |
| PANCREATIC ENZYMES | PANCREAZE -> PREFERRED |
| PHOSPHATE BINDERS | CALCIUM ACETATE -> NON PREFERRED |
| UTERINE DISORDER TREATMENT | MYFEMBREE -> PREFERRED |